100 TECHNOLOGY SQUARE, CAMBRIDGE, MA
Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Investor Presentation
Announces Third Quarter 2025 Financial Results and Recent Business Highlights
Announces Second Quarter 2025 Financial Results and Recent Business Highlights
Shareholder votes
Tectonic Therapeutic's Positive Phase 1b Results for TX45 in Pulmonary Hypertension
Financial Results, Press Release
FY 2024
Q3
Q2
Q1
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Statement of Changes in Beneficial Ownership
S-8 POS
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement